Correlation Between Aerovate Therapeutics and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Black Diamond Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Black Diamond.
Diversification Opportunities for Aerovate Therapeutics and Black Diamond
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aerovate and Black is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Black Diamond go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Black Diamond
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.0 times more return on investment than Black Diamond. However, Aerovate Therapeutics is 1.0 times less risky than Black Diamond. It trades about 0.24 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 218.00 in Aerovate Therapeutics on August 28, 2024 and sell it today you would earn a total of 50.00 from holding Aerovate Therapeutics or generate 22.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Aerovate Therapeutics |
| Black Diamond Therap |
Aerovate Therapeutics and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Black Diamond
The main advantage of trading using opposite Aerovate Therapeutics and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |